|
TMED4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.84480000007004E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.37989999996024E-06 |
| Normal-vs-Stage2 |
2.204000E-01 |
| Normal-vs-Stage3 |
1.347699996046E-08 |
| Normal-vs-Stage4 |
8.82069994823098E-09 |
| Stage1-vs-Stage2 |
7.476500E-03 |
| Stage1-vs-Stage3 |
2.081800E-02 |
| Stage1-vs-Stage4 |
4.104300E-02 |
| Stage2-vs-Stage3 |
2.191700E-04 |
| Stage2-vs-Stage4 |
3.982300E-04 |
| Stage3-vs-Stage4 |
8.360000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.25210000052101E-07 |
| Normal-vs-AfricanAmerican |
8.281000E-03 |
| Normal-vs-Asian |
7.82339970584189E-10 |
| Caucasian-vs-AfricanAmerican |
5.702600E-01 |
| Caucasian-vs-Asian |
1.158400E-02 |
| AfricanAmerican-vs-Asian |
7.985700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.44390000000882E-06 |
| Normal-vs-Female |
1.23969999998863E-06 |
| Male-vs-Female |
4.706400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.01889999957339E-07 |
| Normal-vs-Age(41-60Yrs) |
1.16309999997899E-06 |
| Normal-vs-Age(61-80Yrs) |
2.09419999999128E-05 |
| Normal-vs-Age(81-100Yrs) |
8.639300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.822800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.841800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.910000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.259600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.099200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.939600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.03659999981265E-07 |
| Classical-VS-Follicular |
9.410900E-04 |
| Classical-VS-Other |
5.381600E-01 |
| Classical-VS-Normal |
3.81620000045046E-07 |
| Tall-VS-Follicular |
4.24239976481999E-10 |
| Tall-VS-Other |
3.087600E-01 |
| Tall-VS-Normal |
5.3179682879545E-14 |
| Follicular-VS-Other |
1.348190E-01 |
| Follicular-VS-Normal |
5.682100E-02 |
| Other-VS-Normal |
6.319500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.94030000000489E-05 |
| Normal-vs-N1 |
1.16260334692697E-11 |
| N0-vs-N1 |
1.95221000000023E-05 |
|
|
